Which Factors Will Push The Chronic Liver Diseases Therapeutics Market To Achieve $23.63 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Chronic Liver Diseases Therapeutics Market?
The market size for therapeutics treating chronic liver diseases has seen a swift expansion in recent times. The forecast suggests an increase from $14.38 billion in 2024 to $15.88 billion in 2025 with a compound annual growth rate (CAGR) of 10.4%. The historic growth can be attributed to the rise in viral hepatitis cases, escalated obesity rates, an aging population, heightened awareness about liver health, and improved patient accessibility to treatment.
In the coming years, the therapeutics market for chronic liver diseases is projected to experience swift expansion, with an expected growth to $23.63 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. This anticipated growth is due to a heightened focus on personalized medicine, an increasing pipeline of innovative therapies, the expansion of telemedicine and digital health solutions, and increasing demand for programs aimed at preventing liver disease, along with a surge in viral hepatitis incidents. Significant trends include the usage of artificial intelligence in diagnostics, biologics and gene therapies, non-invasive treatment alternatives, combined therapies, and the proliferation of patient-centered care models.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21145&type=smp
What Underlying Factors Are Supporting The Chronic Liver Diseases Therapeutics Market Growth?
The chronic liver disease therapeutics market is projected to flourish due to the escalating prevalence of alcohol use. Drinking alcohol, which involves the consumption of beverages containing ethanol to various extents, can result in numerous health implications, and it’s on the rise due to increasing societal acceptance, enhanced incomes, and improved availability across the globe. Treatments for chronic liver disease play a vital role in managing liver damage induced by excessive alcohol usage, curbing the disease’s advancement and restoring liver performance. For instance, the First Citizens Bank, a US-based financial institution, reported a 1.2% rise in direct-to-consumer (DTC) wine case sales in 2023 compared to 2022 as of June 2024. Additionally, a report released by the Japan’s Kirin Holdings Company Limited, a beverage firm, in December 2023 indicated that there was a consumption of approximately 192.1 million kiloliters of beer in 2022, which marked a 2.9% surge from the previous year. Consequently, the surge in alcohol intake is fueling the expansion of the market for chronic liver disease therapeutics.
How Does The Chronic Liver Diseases Therapeutics Market Differ By Segment?
The chronic liver diseases therapeuticsmarket covered in this report is segmented –
1) By Treatment Type: Antiviral Drugs; Immunosuppressants Vaccines; Immunoglobulins; Corticosteroids; Targeted Therapy; Chemotherapy
2) By Disease Type: Hepatitis; Autoimmune Diseases; Non-Alcoholic Fatty Liver Disease; Cancer; Genetic Disorders
3) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Antiviral Drugs: Nucleoside Or Nucleotide Analogues; Interferons; Direct-Acting Antivirals
2) By Immunosuppressants: Calcineurin Inhibitors; mTOR Inhibitors; Purine Synthesis Inhibitors
3) By Vaccines: Hepatitis A Vaccine; Hepatitis B Vaccine; Combination Hepatitis Vaccines
4) By Immunoglobulins: Hepatitis B Immune Globulin; Intravenous Immunoglobulin
5) By Corticosteroids: Prednisolone; Methylprednisolone; Dexamethasone
6) By Targeted Therapy: Tyrosine Kinase Inhibitors; Monoclonal Antibodies
7) By Chemotherapy: Systemic Chemotherapy; Transarterial Chemoembolization Agents
What New Opportunities Are Emerging From Trends In The Chronic Liver Diseases Therapeutics Market?
Key corporations in the chronic liver diseases therapeutics sector are aiming towards advanced innovation through the creation of RNA therapies that can target underlying genetic and molecular mechanisms, thereby providing enhanced and personalized treatment options. RNA therapies, which are premium medical solutions, use RNA molecules to manage gene expression or protein production with an objective to prevent or treat diseases by focusing on particular genetic mechanisms. For example, in May 2022, Ochre Bio, a biotech firm based in the UK, inaugurated its cutting-edge ‘Liver ICU’ research facility at BioLabs@NYULangone, a biopharmaceutical incubator located in New York City. This state-of-the-art center evaluates the efficacy of upcoming RNA therapeutics using whole human livers maintained on perfusion machines. Making use of discarded donor livers in research, the facility’s goal is to hasten the drug development process and enhance the accuracy of liver treatment studies by mimicking human physiological conditions.
Who Are The Global Leaders Steering The Chronic Liver Diseases Therapeutics Market Forward?
Major companies operating in the chronic liver diseases therapeutics market are F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Dr. Reddy’s Laboratories Ltd., Vir Biotechnology Inc., Alnylam Pharmaceuticals Inc., Indian Immunologicals Limited, Intercept Pharmaceuticals Inc., Viking Therapeutics Inc., Ascletis Pharma Inc., Ochre Bio Limited, Tiziana Life Sciences Ltd., Antios Therapeutics Inc.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Chronic Liver Diseases Therapeutics Market?
North America was the largest region in the chronic liver diseases therapeutics market in 2024. The regions covered in the chronic liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21145&type=smp
Browse Through More Reports Similar to the Global Chronic Liver Diseases Therapeutics Market 2025, By The Business Research Company
Chronic Pain Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Chronic Myeloid Leukemia Cml Treatment Global Market Report 2025
Chronic Cough Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
